Ubiquitin Pathway in VHL Cancer Syndrome
Open Access
- 1 August 2006
- Vol. 8 (8) , 623-629
- https://doi.org/10.1593/neo.06442
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Characterization of a von Hippel Lindau Pathway Involved in Extracellular Matrix Remodeling, Cell Invasion, and AngiogenesisCancer Research, 2006
- Tumor Suppression by the von Hippel-Lindau Protein Requires Phosphorylation of the Acidic DomainJournal of Biological Chemistry, 2005
- Inactivation of the Arylhydrocarbon Receptor Nuclear Translocator (Arnt) Suppresses von Hippel-Lindau Disease-Associated Vascular Tumors in MiceMolecular and Cellular Biology, 2005
- von Hippel-Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney CancerAmerican Journal of Nephrology, 2004
- Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complexNature, 2002
- Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor proteinThe EMBO Journal, 2000
- Covalent modifier NEDD8 is essential for SCF ubiquitin-ligase in fission yeastThe EMBO Journal, 2000
- Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC IsotypesBiochemical and Biophysical Research Communications, 1999
- Hereditary Renal-Cell Carcinoma Associated with a Chromosomal TranslocationNew England Journal of Medicine, 1979
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971